216 related articles for article (PubMed ID: 24937048)
1. Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease.
Pereira IR; Vilar-Pereira G; Silva AA; Lannes-Vieira J
Mem Inst Oswaldo Cruz; 2014 Jun; 109(3):289-98. PubMed ID: 24937048
[TBL] [Abstract][Full Text] [Related]
2. Inducible nitric oxide synthase in heart tissue and nitric oxide in serum of Trypanosoma cruzi-infected rhesus monkeys: association with heart injury.
Carvalho CM; Silverio JC; da Silva AA; Pereira IR; Coelho JM; Britto CC; Moreira OC; Marchevsky RS; Xavier SS; Gazzinelli RT; da Glória Bonecini-Almeida M; Lannes-Vieira J
PLoS Negl Trop Dis; 2012; 6(5):e1644. PubMed ID: 22590660
[TBL] [Abstract][Full Text] [Related]
3. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
Front Immunol; 2020; 11():306. PubMed ID: 32194558
[TBL] [Abstract][Full Text] [Related]
4. Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.
Silverio JC; de-Oliveira-Pinto LM; da Silva AA; de Oliveira GM; Lannes-Vieira J
Int J Exp Pathol; 2010 Feb; 91(1):72-86. PubMed ID: 19878357
[TBL] [Abstract][Full Text] [Related]
5. In Chagas disease, transforming growth factor beta neutralization reduces
Ferreira RR; de Souza EM; Vilar-Pereira G; Degrave WMS; Abreu RDS; Meuser-Batista M; Ferreira NVC; Ledbeter S; Barker RH; Bailly S; Feige JJ; Lannes-Vieira J; de Araújo-Jorge TC; Waghabi MC
Front Cell Infect Microbiol; 2022; 12():1017040. PubMed ID: 36530434
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T-cells expressing interferon gamma or perforin play antagonistic roles in heart injury in experimental Trypanosoma cruzi-elicited cardiomyopathy.
Silverio JC; Pereira IR; Cipitelli Mda C; Vinagre NF; Rodrigues MM; Gazzinelli RT; Lannes-Vieira J
PLoS Pathog; 2012; 8(4):e1002645. PubMed ID: 22532799
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage.
Medeiros GA; Silvério JC; Marino AP; Roffê E; Vieira V; Kroll-Palhares K; Carvalho CE; Silva AA; Teixeira MM; Lannes-Vieira J
Microbes Infect; 2009 Feb; 11(2):264-73. PubMed ID: 19100857
[TBL] [Abstract][Full Text] [Related]
8. A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.
Pereira IR; Vilar-Pereira G; Marques V; da Silva AA; Caetano B; Moreira OC; Machado AV; Bruna-Romero O; Rodrigues MM; Gazzinelli RT; Lannes-Vieira J
PLoS Pathog; 2015 Jan; 11(1):e1004594. PubMed ID: 25617628
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline reverses chronic experimental Chagasic cardiomyopathy in association with repositioning of abnormal CD8+ T-cell response.
Pereira IR; Vilar-Pereira G; Moreira OC; Ramos IP; Gibaldi D; Britto C; Moraes MO; Lannes-Vieira J
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003659. PubMed ID: 25789471
[TBL] [Abstract][Full Text] [Related]
10. Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease.
Vilar-Pereira G; Resende Pereira I; de Souza Ruivo LA; Cruz Moreira O; da Silva AA; Britto C; Lannes-Vieira J
Antimicrob Agents Chemother; 2016 Jul; 60(7):4297-309. PubMed ID: 27161638
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease.
Pereira IR; Vilar-Pereira G; Silva AA; Moreira OC; Britto C; Sarmento ED; Lannes-Vieira J
Mediators Inflamm; 2014; 2014():798078. PubMed ID: 25140115
[TBL] [Abstract][Full Text] [Related]
12. Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease.
Marinho CR; Bucci DZ; Dagli ML; Bastos KR; Grisotto MG; Sardinha LR; Baptista CR; Gonçalves CP; Lima MR; Alvarez JM
Infect Immun; 2004 Apr; 72(4):2350-7. PubMed ID: 15039360
[TBL] [Abstract][Full Text] [Related]
13. TNF/TNFR1 signaling up-regulates CCR5 expression by CD8+ T lymphocytes and promotes heart tissue damage during Trypanosoma cruzi infection: beneficial effects of TNF-alpha blockade.
Kroll-Palhares K; Silvério JC; Silva AA; Michailowsky V; Marino AP; Silva NM; Carvalho CM; Pinto LM; Gazzinelli RT; Lannes-Vieira J
Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):375-85. PubMed ID: 18660993
[TBL] [Abstract][Full Text] [Related]
14. Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy.
Farani PSG; Begum K; Vilar-Pereira G; Pereira IR; Almeida IC; Roy S; Lannes-Vieira J; Moreira OC
Front Cell Infect Microbiol; 2021; 11():692655. PubMed ID: 34381739
[TBL] [Abstract][Full Text] [Related]
15. The Syrian hamster as a model for the dilated cardiomyopathy of Chagas' disease: a quantitative echocardiographical and histopathological analysis.
Bilate AM; Salemi VM; Ramires FJ; de Brito T; Silva AM; Umezawa ES; Mady C; Kalil J; Cunha-Neto E
Microbes Infect; 2003 Oct; 5(12):1116-24. PubMed ID: 14554253
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with Chagas disease.
Cutrullis RA; Petray PB; Schapachnik E; Sánchez R; Postan M; González MN; Martín V; Corral RS
PLoS One; 2013; 8(2):e57181. PubMed ID: 23451183
[TBL] [Abstract][Full Text] [Related]
17. TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas' heart disease.
Ferreira RR; Abreu RDS; Vilar-Pereira G; Degrave W; Meuser-Batista M; Ferreira NVC; da Cruz Moreira O; da Silva Gomes NL; Mello de Souza E; Ramos IP; Bailly S; Feige JJ; Lannes-Vieira J; de Araújo-Jorge TC; Waghabi MC
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007602. PubMed ID: 31365537
[TBL] [Abstract][Full Text] [Related]
18. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient.
Cunha-Neto E; Coelho V; Guilherme L; Fiorelli A; Stolf N; Kalil J
J Clin Invest; 1996 Oct; 98(8):1709-12. PubMed ID: 8878420
[TBL] [Abstract][Full Text] [Related]
20. L-arginine supplementation increases cardiac collagenogenesis in mice chronically infected with Berenice-78 Trypanosoma cruzi strain.
Bianchini Narde M; Belli Cassa Domingues EL; Ribeiro Gonçalves K; Lomar Viana M; Santos Zanini M; Geraldo de Lima W; Bahia MT; Matos Dos Santos F
Parasitol Int; 2021 Aug; 83():102345. PubMed ID: 33857596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
